Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
A systematic review of angiotensin receptor blockers in preventing stroke Lu GC; Cheng JW; Zhu KM; Ma XJ; Shen FM; Su DFStroke 2009[Dec]; 40 (12): 3876-8BACKGROUND AND PURPOSE: Angiotensin receptor blockers are widely used in patients at high risk of cardiocerebrovascular events. The aim of this meta-analysis was to investigate the effects of angiotensin receptor blockers on the risk of stroke. METHODS: Electronic searches of MEDLINE, EMBASE, and the Cochrane central register of controlled trials were performed. A total of 20 randomized clinical trials with 108 286 patients reporting stroke were available for this clinical outcome analysis. RESULTS: Angiotensin receptor blockers were associated with a significant reduction in the risk of stroke than placebo with an OR of 0.91 (0.84 to 0.98). Angiotensin receptor blockers were associated with no significant reduction in the risk of stroke compared with angiotensin-converting enzyme inhibitors (OR, 0.93; 0.84 to 1.03) and calcium antagonists (OR, 1.16; 0.91 to 1.48). CONCLUSIONS: Evidence of the benefit of angiotensin receptor blockers on the risk of stroke is provided when compared with placebo. There was no evidence of the benefit when comparing angiotensin receptor blockers with angiotensin-converting enzyme inhibitors and with calcium antagonists.|*Angiotensin Receptor Antagonists[MESH]|Angiotensin II/*antagonists & inhibitors/*physiology[MESH]|Angiotensin-Converting Enzyme Inhibitors/pharmacology[MESH]|Calcium Channel Blockers/pharmacology[MESH]|Cardiovascular Diseases/drug therapy/physiopathology/prevention & control[MESH]|Humans[MESH]|Hypertension/complications/drug therapy/prevention & control[MESH]|Randomized Controlled Trials as Topic/statistics & numerical data[MESH]|Receptors, Angiotensin/*physiology[MESH]|Risk Factors[MESH]|Stroke/*drug therapy/physiopathology/*prevention & control[MESH]|Treatment Outcome[MESH] |
